Overview

Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection

Status:
Completed

Trial end date:
2019-07-19

Target enrollment:

Participant gender:

Summary

The purpose of this study is to demonstrate the non-inferior efficacy of TAK-438 versus lansoprazole in the treatment of participants with duodenal ulcer.

Phase:

Phase 3

Details

Lead Sponsor:

Takeda

Treatments:

Amoxicillin
Bismuth
Clarithromycin
Dexlansoprazole
Lansoprazole
Molecular Mechanisms of Pharmacological Action
Potassium Citrate